The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

Opinion: Orrick's Irena Royzman and Dana Sublett write that judges have done a good job in multiple decisions that protect ...

In our new series "The Fine Print," ABC News' Dr. Tara Narula breaks down what’s on the labels of over-the-counter drugs, ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

Abortion rights supporters say that it would protect telehealth providers as states increase efforts to target them.

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...